Clinical Trial Update: Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma [NA]

View source ↗

Summary

Clinical trial update on CAR-CLD18 T cells for advanced gastric adenocarcinoma and pancreatic adenocarcinoma; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• CAR-CLD18 T Cells

Snippet

Sponsor: Changhai Hospital | Conditions: Advanced Gastric Adenocarcinoma, Pancreatic Adenocarcinoma | NA | Status: UNKNOWN